Clinical trials
Completed Neuralgia, Postherpetic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
128 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 5 |
| 2003 | 3 |
| 2004 | 7 |
| 2005 | 1 |
| 2006 | 8 |
| 2007 | 9 |
| 2008 | 9 |
| 2009 | 6 |
| 2010 | 7 |
| 2011 | 9 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 128 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 8 |
| NeurogesX | 5 |
| Pfizer | 4 |
| UCB Pharma | 4 |
| Depomed | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Odense University Hospital | 3 |
| Allergan | 2 |
| Asan Medical Center | 2 |
| Daiichi Sankyo Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuralgia, Postherpetic | 128 |
| Herpes Zoster | 38 |
| Neuralgia | 36 |
| Pain | 19 |
| Chronic Pain | 10 |
| Diabetic Neuropathies | 10 |
| Complex Regional Pain Syndromes | 8 |
| Peripheral Nervous System Diseases | 7 |
| Peripheral Nerve Injuries | 5 |
| Postoperative Pain | 4 |
Trials
Showing 51 to 75 of 128. Each trial links to its page on Pharma Observatory.
28 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.